• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4'-表阿霉素与阿霉素心脏毒性的比较研究

[A comparative study of 4'-epi-doxorubicin and doxorubicin cardiotoxicities].

作者信息

Suzuki T, Yamamoto H, Iwasaki T, Okamoto S, Iizuka T, Kanda H, Murata K

出版信息

Gan To Kagaku Ryoho. 1984 Oct;11(10):2170-6.

PMID:6593004
Abstract

The cardiotoxicities of 4'-epidoxorubicin (4-epiDX) and doxorubicin (DX) were compared in rabbits. Thirty-one male NZW rabbits weighing 2.4 to 2.6 kg were used for each compound and 15 were kept as controls. DX or 4'-epiDX was administered intravenously with a dose of 0.8 mg/kg for 3 consecutive days a week for 5-10 weeks. Rabbits were sacrificed at 5, 8 and 10 weeks after initial administration. Under nembutal anesthesia, electrocardiogram, phonocardiogram and carotidgram were recorded. Light and electron microscopic studies of the heart were performed according to conventional methods. Myocardial alterations were semi-quantitatively evaluated with light microscopy, using a modified grading system derived from Bertazzoli. Twelve of the DX-treated rabbits and 4 of the 4'-epiDX-treated rabbits died after 5 weeks or later. In the electrocardiogram study, ST-T changes were less frequently observed in rabbits treated with 4'-epiDX than those with DX. Significant increases of PEP/LVET were observed in rabbits treated with DX for 8 and 10 weeks, similar increases were only observed while in rabbits treated with 4'-epiDX for 10 weeks. Histologically, both drugs produced myocardial degeneration and necrosis. The lesions were characterized by multiple vacuolization of myocardial cells, atrophy of myocardial cells, interstitial edema and fibrosis. Myocardial alterations induced by 4'-epiDX were qualitatively similar to those induced by DX, but were much less severe at the same cumulative dose. These results demonstrate that 4'-epiDX is less cardiotoxic than DX.

摘要

在兔子身上比较了4'-表阿霉素(4-epiDX)和阿霉素(DX)的心脏毒性。每种化合物使用31只体重为2.4至2.6千克的雄性新西兰白兔,15只作为对照。以0.8毫克/千克的剂量静脉注射DX或4'-epiDX,每周连续3天,共5至10周。在初次给药后5、8和10周处死兔子。在戊巴比妥麻醉下,记录心电图、心音图和颈动脉图。按照常规方法对心脏进行光镜和电镜研究。使用源自Bertazzoli的改良分级系统,通过光镜对心肌改变进行半定量评估。12只接受DX治疗的兔子和4只接受4'-epiDX治疗的兔子在5周或更晚后死亡。在心电图研究中,4'-epiDX治疗的兔子比DX治疗的兔子更少观察到ST-T改变。接受DX治疗8周和10周的兔子观察到PEP/LVET显著增加,而仅在接受4'-epiDX治疗10周的兔子中观察到类似增加。组织学上,两种药物均引起心肌变性和坏死。病变的特征是心肌细胞多处空泡化、心肌细胞萎缩、间质水肿和纤维化。4'-epiDX诱导的心肌改变在性质上与DX诱导的相似,但在相同累积剂量下严重程度要低得多。这些结果表明,4'-epiDX的心脏毒性低于DX。

相似文献

1
[A comparative study of 4'-epi-doxorubicin and doxorubicin cardiotoxicities].4'-表阿霉素与阿霉素心脏毒性的比较研究
Gan To Kagaku Ryoho. 1984 Oct;11(10):2170-6.
2
Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects.
Int J Clin Pharmacol Ther Toxicol. 1989 May;27(5):217-21.
3
Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats.阿霉素和4'-表阿霉素在小鼠和大鼠体内的比较分布及胆汁排泄研究。
Cancer Treat Rep. 1980 Aug-Sep;64(8-9):897-904.
4
Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits.阿霉素与表阿霉素对兔心血管系统作用的比较研究。
Pol J Pharmacol Pharm. 1989 Nov-Dec;41(6):597-609.
5
Comparison of cardiotoxicity of pirarubicin, epirubicin and doxorubicin in the rat.吡柔比星、表柔比星和多柔比星对大鼠心脏毒性的比较。
Drugs Exp Clin Res. 1994;20(4):153-60.
6
Echocardiographic assessment of anthracycline cardiotoxicity during different therapeutic regimens.
Int J Clin Pharmacol Res. 1987;7(4):307-11.
7
Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.通过包裹于长循环聚乙二醇化脂质体中降低阿霉素对兔和犬的心脏毒性。
J Pharmacol Exp Ther. 1999 May;289(2):1128-33.
8
NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.美国国家毒理学计划关于灌胃给予F344大鼠和B6C3F1小鼠瑞得灵(化学物质登记号:23246-96-0)的毒性研究技术报告
Toxic Rep Ser. 1993 Dec;27:1-D9.
9
The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.米托蒽醌治疗对先前接受过最小心脏毒性剂量阿霉素治疗的比格犬的影响。
Am J Pathol. 1987 Jul;128(1):121-30.
10
Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.表柔比星与多柔比星的比较代谢与药代动力学。一项交叉研究。
Cancer Chemother Pharmacol. 1988;21(3):221-8. doi: 10.1007/BF00262774.

引用本文的文献

1
Different anthracycline derivates for reducing cardiotoxicity in cancer patients.用于降低癌症患者心脏毒性的不同蒽环类衍生物。
Cochrane Database Syst Rev. 2010 May 12;2010(5):CD005006. doi: 10.1002/14651858.CD005006.pub4.
2
Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: comparative study with doxorubicin.新型蒽环类衍生物(SM - 5887)静脉注射给兔子后的心脏毒性:与阿霉素的对比研究
Invest New Drugs. 1997;15(3):219-25. doi: 10.1023/a:1005862730941.